143 related articles for article (PubMed ID: 10095878)
1. Microinvasive carcinoma of the breast: a diagnosis in search of a definition.
Schnitt SJ
Adv Anat Pathol; 1998 Nov; 5(6):367-72. PubMed ID: 10095878
[TBL] [Abstract][Full Text] [Related]
2. Observations on the histopathologic diagnosis of microinvasive carcinoma of the breast.
Prasad ML; Osborne MP; Hoda SA
Anat Pathol; 1998; 3():209-32. PubMed ID: 10389587
[TBL] [Abstract][Full Text] [Related]
3. Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas.
de Mascarel I; MacGrogan G; Mathoulin-Pélissier S; Soubeyran I; Picot V; Coindre JM
Cancer; 2002 Apr; 94(8):2134-42. PubMed ID: 12001109
[TBL] [Abstract][Full Text] [Related]
4. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
5. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
Bofin AM; Lydersen S; Hagmar BM
Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
[TBL] [Abstract][Full Text] [Related]
6. Ductal carcinoma in situ and microinvasive disease. American College of Radiology. ACR Appropriateness Criteria.
Rabinovitch RA; Solin LJ; Shank BM; Haffty BG; Halberg FE; Martinez AA; McCormick B; McNeese MD; Mendenhall NP; Mitchell SE; Taylor ME; Singletary SE; Leibel S
Radiology; 2000 Jun; 215 Suppl():1137-52. PubMed ID: 11037538
[No Abstract] [Full Text] [Related]
7. Cytologic diagnosis of male breast cancer with nipple discharge. A case report.
Fujii M; Ishii Y; Wakabayashi T; Itoyanagi N; Hagiwara K; Saito M; Takahashi M
Acta Cytol; 1986; 30(1):21-4. PubMed ID: 3004078
[TBL] [Abstract][Full Text] [Related]
8. [Ductal carcinoma in situ of the breast with microinvasion. Role of sentinel lymph node biopsy].
Le Bouëdec G; de Lapasse C; Mishellany F; Chêne G; Michy T; Gimbergues P; Dauplat J
Gynecol Obstet Fertil; 2007 Apr; 35(4):317-22. PubMed ID: 17344087
[TBL] [Abstract][Full Text] [Related]
9. Microinvasive breast cancer and the role of sentinel node biopsy: an institutional experience and review of the literature.
Guth AA; Mercado C; Roses DF; Darvishian F; Singh B; Cangiarella JF
Breast J; 2008; 14(4):335-9. PubMed ID: 18537917
[TBL] [Abstract][Full Text] [Related]
10. [Management of ductal carcinoma in situ by the pathologist: current questions].
Arnould L; Caron Y; Sigal-Zafrani B
Ann Pathol; 2003 Dec; 23(6):534-46. PubMed ID: 15094591
[TBL] [Abstract][Full Text] [Related]
11. Understanding ductal carcinoma in situ: a step in the right direction.
Morrow M
Cancer; 1999 Aug; 86(3):375-7. PubMed ID: 10430242
[No Abstract] [Full Text] [Related]
12. [The concept of carcinoma in situ].
Andersen JA; Schiødt T
Ugeskr Laeger; 1980 Mar; 142(14):867-9. PubMed ID: 6250258
[No Abstract] [Full Text] [Related]
13. Biology of ductal carcinoma in situ classification based on biologic potential.
Tsikitis VL; Chung MA
Am J Clin Oncol; 2006 Jun; 29(3):305-10. PubMed ID: 16755185
[TBL] [Abstract][Full Text] [Related]
14. [Cytodiagnosis of invasive ductal breast cancer].
Finsterer H
Verh Dtsch Ges Pathol; 1985; 69():502-7. PubMed ID: 3006391
[No Abstract] [Full Text] [Related]
15. Sentinel lymph node positivity of patients with ductal carcinoma in situ or microinvasive breast cancer.
Katz A; Gage I; Evans S; Shaffer M; Fleury T; Smith FP; Flax R; Drogula C; Petrucci P; Magnant C
Am J Surg; 2006 Jun; 191(6):761-6. PubMed ID: 16720145
[TBL] [Abstract][Full Text] [Related]
16. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions.
Barth PJ; Ebrahimsade S; Ramaswamy A; Moll R
Virchows Arch; 2002 Mar; 440(3):298-303. PubMed ID: 11889601
[TBL] [Abstract][Full Text] [Related]
17. Radiation therapy for ductal carcinoma in situ: is it really worth it?
Thorat MA; Parmar V; Nadkarni MS; Badwe RA
J Clin Oncol; 2007 Feb; 25(4):461-2; author reply 462. PubMed ID: 17264349
[No Abstract] [Full Text] [Related]
18. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
[TBL] [Abstract][Full Text] [Related]
19. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
20. Expression of metalloproteases and their inhibitors by tumor and stromal cells in ductal carcinoma in situ of the breast and their relationship with microinvasive events.
González LO; González-Reyes S; Junquera S; Marín L; González L; Del Casar JM; González JM; Vizoso F
J Cancer Res Clin Oncol; 2010 Sep; 136(9):1313-21. PubMed ID: 20127359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
